You are here

AstraZeneca

AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR

Pharmaceutical Business Review

Thu, 02/28/19 - 11:45 pm

type 2 diabetes

AstraZeneca, Merck notch another major Lynparza trial win — this time in pancreatic cancer

Endpoints

Tue, 02/26/19 - 09:34 am

pancreatic cancer

clinical trials

BRCA-mutated prostate cancer

AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study

Endpoints

Mon, 02/25/19 - 09:50 am

clinical trials

The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress

Stat

Thu, 02/21/19 - 12:41 pm

Richard Gonzalez

Jennifer Taubert

Olivier Brandicourt

Giovanni Caforio

Bristol-Myers Squibb

2 Pharma Stocks in the Middle of an Oncology Sales Explosion

Motley Fool

Tue, 02/19/19 - 08:01 pm

AZ’s CEO dismisses “fake news” about his imminent departure

Pharmaforum

Thu, 02/14/19 - 12:00 pm

AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales

Yahoo/Zacks.com

Thu, 02/14/19 - 09:51 am

AstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D

Endpoints

Thu, 02/14/19 - 09:43 am

With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market

BioSpace

Wed, 02/13/19 - 10:06 am

Powerful Senate committee invites pharma executives to testify

Reuters

Tue, 02/5/19 - 11:31 pm

Bristol-Myers Squibb

AZ’s lung drug gets fast development in EU and US

Pharmaforum

Tue, 02/5/19 - 09:49 am

AstraZeneca’s Forxiga recommended for marketing authorization in EU

Pharmaceutical Business Review

Mon, 02/4/19 - 09:52 am

type 1 diabetes

AstraZeneca and UPMC Health Plan Form Unique Outcome Based Agreement

CP Wire

Mon, 01/28/19 - 12:52 pm

outcomes-based contracts

AstraZeneca and UPMC Health Plan Form Unique Outcome Based Agreement

Mon, 01/28/19 - 12:52 pm

Based On Sales Forecasts For 2018 FDA Approved Drugs, Big Pharma Not Just Focused On Blockbusters

Forbes

Mon, 01/28/19 - 11:00 am

Gilead Sciences

Vertex Pharmaceuticals

Is the Smoldering NASH Market Ready to Burst Into Flames?

BioSpace

Tue, 01/22/19 - 11:52 am

Gilead Sciences

Bristol-Myers Squibb

Intercept Pharmaceuticals

Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?

Yahoo/Motley Fool

Sun, 01/20/19 - 03:20 pm

Women in Science: AstraZeneca

Pharmaforum

Sat, 01/19/19 - 06:17 pm

women executives

AstraZeneca Departures Continue as Medical Chief Bohen Exits

Bloomberg

Mon, 01/14/19 - 11:05 am

JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies

BioSpace

Thu, 01/10/19 - 08:48 pm

SAGE Therapeutics

Denali Therapeutics

government shutdown

Pages